Background/Aim: Anti-angiogenic treatment is a promising strategy for cancer therapy and is
currently evaluated in clinical trials. The aim of the present study was to further investigate …

To investigate the feasibility of contrast-enhanced ultrasound (CEUS) with perflubutane for
evaluating anti-angiogenic effects, we assessed the contrast enhancement of mice xenograft …

Contrast-enhanced computed tomography (CECT) and contrast-enhanced destruction-
replenishment subharmonic ultrasound (CEDRSU) were used to quantify blood flow and …

Objectives Contrast‐enhanced ultrasound (US) and targeted microbubbles have been
shown to be advantageous for angiogenesis evaluation and disease staging in cancer. This …

Angiogenesis, the development of new blood vessels, is necessary for tumor growth. Anti-
angiogenic therapies have recently received attention as a possible cancer treatment. The …

Purpose The purpose of this study was to assess tumor angiogenesis using contrast-
enhanced ultrasonography (CEUS) of human prostate cancer cells (PC3) that were …

Angiogenesis regulation is one of the newest fronts in the fight against cancer. Anti-
angiogenic therapy is based on inhibiting factors required to solicit vessel formation thus …

Molecular ultrasound is capable of elucidating the expression of angiogenic markers in vivo.
However, the capability of the method for volumetric “multitarget quantification” and for the …

Microvascular endothelial cells, which are recruited by tumors, have become an important
target in cancer therapy. This study firstly examined the antitumor effect of angiogenesis …

The aim of the study was to quantitatively assess tumor microcirculation upon vascular
targeting tumor therapy by non-destructive contrast enhanced ultrasonography (CEUS) and …